anmelden
OMX Nordic 40
2.719,46
PKT
+3,93
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.06.22 | Novo Nordisk Sell | UBS AG | |
| 24.06.22 | Novo Nordisk Neutral | UBS AG | |
| 24.06.22 | Volvo (B) Buy | Deutsche Bank AG | |
| 24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.06.22 | Volvo (B) Sell | UBS AG | |
| 23.06.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 23.06.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 22.06.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 22.06.22 | Kone Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.06.22 | Kone Sell | Goldman Sachs Group Inc. | |
| 21.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 20.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 20.06.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.06.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.06.22 | Fortum Underperform | Bernstein Research | |
| 17.06.22 | Nokia Buy | Goldman Sachs Group Inc. | |
| 17.06.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.22 | Kone Outperform | Credit Suisse Group | |
| 16.06.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 14.06.22 | Fortum Overweight | JP Morgan Chase & Co. | |
| 14.06.22 | AstraZeneca Neutral | UBS AG | |
| 13.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 13.06.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.06.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 13.06.22 | Kone Equal Weight | Barclays Capital | |
| 13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
| 08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.06.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.06.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. |
